NFATC3 and hepatocellular carcinoma: In contrast, another study found that the level of circNFATC3 was positively correlated with NFATC3 mRNA, and high NFATC3 expression predicted a better prognosis; thus, circNFATC3 may be a biomarker for favorable prognosis in HCC patients (Jia et al., 2021).